Pharma Journalist 8801 posts 0 comments

SOM Biotech announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates inhibit the main protease of SARS-CoV-2 and…
Read More...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of…
Read More...

SMi Reports: The upcoming Highly Potent Active Pharmaceutical Ingredients conference is now via remote access only – 3 weeks to go Due to the COVID-19 outbreak, SMi Group has made…
Read More...

According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd  has received emergency use authorization (EUA) from FDA for…
Read More...

Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of ruxolitinib (Jakafi)…
Read More...

HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19…
Read More...

Smithers’ 9th annual industry-leading Extractables and Leachables USA Conference has been postponed in light of COVID-19 developments. The event will now take place October 26-28, 2020.…
Read More...

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that it…
Read More...

Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless cancers and autoimmune…
Read More...

FORMA Therapeutics, Inc. (FORMA), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced that the U.S. Food and Drug Administration (FDA)…
Read More...